Healthcare provider profile · identity verified

Christopher West, NP

Nurse Practitioner · EUREKA, CA · NPI 1316293467

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	339	99
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	304	58
Ozempic	Semaglutide	234	48
Levothyroxine Sodium	Levothyroxine Sodium	192	38
Amlodipine Besylate	Amlodipine Besylate	182	58
Gabapentin	Gabapentin	182	43
Jardiance	Empagliflozin	169	35
Pantoprazole Sodium	Pantoprazole Sodium	167	33
Lisinopril	Lisinopril	164	44
Metformin Hcl Er	Metformin Hcl	148	38
Albuterol Sulfate Hfa	Albuterol Sulfate	135	40
Omeprazole	Omeprazole	133	39
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	122	19
Buprenorphine Hcl	Buprenorphine Hcl	111	13
Metoprolol Succinate	Metoprolol Succinate	108	29
Pregabalin	Pregabalin	105	16
Metformin Hcl	Metformin Hcl	104	29
Trulicity	Dulaglutide	104	22
Losartan Potassium	Losartan Potassium	103	31
Tamsulosin Hcl	Tamsulosin Hcl	101	32
Benazepril Hcl	Benazepril Hcl	99	27
Famotidine	Famotidine	96	26
Mounjaro	Tirzepatide	92	15
Tresiba Flextouch U-200	Insulin Degludec	92	18
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	89	25
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	79	15
Rosuvastatin Calcium	Rosuvastatin Calcium	79	23
Duloxetine Hcl	Duloxetine Hcl	76	16
Hydrochlorothiazide	Hydrochlorothiazide	74	21
Baclofen	Baclofen	73	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	72	23
Eliquis	Apixaban	60	13
Furosemide	Furosemide	60	13
Potassium Chloride	Potassium Chloride	60	suppressed
Trazodone Hcl	Trazodone Hcl	56	13
Fluticasone Propionate	Fluticasone Propionate	55	22
Hydroxyzine Hcl	Hydroxyzine Hcl	54	12
Januvia	Sitagliptin Phosphate	53	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	50	14
Novolog Flexpen	Insulin Aspart	49	17
Simvastatin	Simvastatin	49	suppressed
Tramadol Hcl	Tramadol Hcl	46	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	45	13
Valsartan	Valsartan	45	12
Ibuprofen	Ibuprofen	43	19
Mirtazapine	Mirtazapine	40	12
Ondansetron Odt	Ondansetron	40	12
Sertraline Hcl	Sertraline Hcl	40	suppressed
Lidocaine	Lidocaine	39	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	39	suppressed
Ropinirole Hcl	Ropinirole Hcl	38	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	38	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	36	12
Novolog	Insulin Aspart	36	suppressed
Pravastatin Sodium	Pravastatin Sodium	36	suppressed
Bupropion Xl	Bupropion Hcl	35	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	35	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	35	18
Donepezil Hcl	Donepezil Hcl	33	suppressed
Glipizide Er	Glipizide	33	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	33	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	32	suppressed
Allopurinol	Allopurinol	31	suppressed
Humulin R U-500 Kwikpen	Insulin Regular, Human	31	suppressed
Prazosin Hcl	Prazosin Hcl	31	suppressed
Repatha Sureclick	Evolocumab	31	suppressed
Celecoxib	Celecoxib	30	suppressed
Alendronate Sodium	Alendronate Sodium	29	11
Humira(Cf) Pen	Adalimumab	29	suppressed
Oxycodone Hcl	Oxycodone Hcl	29	suppressed
Prednisone	Prednisone	29	suppressed
Breyna	Budesonide/Formoterol Fumarate	28	suppressed
Humalog	Insulin Lispro	27	suppressed
Naltrexone Hcl	Naltrexone Hcl	26	suppressed
Omnipod 5 Dexg7g6 Pods (Gen 5)	Insulin Pump Cart,auto,bt,g6/7	26	suppressed
Clonazepam	Clonazepam	25	suppressed
Carvedilol	Carvedilol	24	suppressed
Montelukast Sodium	Montelukast Sodium	24	suppressed
Nystatin	Nystatin	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Varenicline Tartrate	Varenicline Tartrate	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Belbuca	Buprenorphine Hcl	22	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	22	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Lorazepam	Lorazepam	22	suppressed
Olanzapine	Olanzapine	22	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	21	suppressed
Incruse Ellipta	Umeclidinium Bromide	21	suppressed
Meloxicam	Meloxicam	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Verapamil Er	Verapamil Hcl	21	suppressed
Carisoprodol	Carisoprodol	20	suppressed
Humalog Kwikpen U-200	Insulin Lispro	20	suppressed
Hydroxyurea	Hydroxyurea	20	suppressed
Atenolol	Atenolol	19	suppressed
Tresiba Flextouch U-100	Insulin Degludec	19	suppressed
Aripiprazole	Aripiprazole	18	suppressed
Doxepin Hcl	Doxepin Hcl	18	suppressed
Finasteride	Finasteride	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Clotrimazole	Clotrimazole	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Rybelsus	Semaglutide	17	suppressed
Techlite Pen Needle	Pen Needle, Diabetic	17	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	16	suppressed
Insulin Lispro	Insulin Lispro	16	suppressed
Ketoconazole	Ketoconazole	16	11
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Glimepiride	Glimepiride	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Testosterone Cypionate	Testosterone Cypionate	14	suppressed
Aimovig Autoinjector	Erenumab-Aooe	13	suppressed
Methenamine Hippurate	Methenamine Hippurate	13	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	13	suppressed
Mexiletine Hcl	Mexiletine Hcl	13	suppressed
Misoprostol	Misoprostol	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Pulmicort Flexhaler	Budesonide	13	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	13	suppressed
Terbinafine Hcl	Terbinafine Hcl	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Fluocinolone Acetonide	Fluocinolone Acetonide	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Naproxen	Naproxen	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Diazepam	Diazepam	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	11
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Exemestane	Exemestane	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Letrozole	Letrozole	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error